Remus Pharmaceuticals Limited (NSE:REMUS)
India
· Delayed Price · Currency is INR 699.80
+41.80 (6.35%)
Apr 29, 2026, 3:29 PM IST
Remus Pharmaceuticals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| Market Capitalization | 7,671 | 13,192 | 10,163 | - | - | - | Upgrade
|
| Market Cap Growth | -41.95% | 29.81% | - | - | - | - | Upgrade
|
| Enterprise Value | 7,932 | 13,164 | 10,212 | - | - | - | Upgrade
|
| Last Close Price | 658.00 | 1118.05 | 860.48 | - | - | - | Upgrade
|
| PE Ratio | 24.04 | 45.38 | 49.53 | - | - | - | Upgrade
|
| PS Ratio | 1.03 | 2.13 | 4.77 | - | - | - | Upgrade
|
| PB Ratio | 2.27 | 4.67 | 5.80 | - | - | - | Upgrade
|
| P/TBV Ratio | 2.57 | 5.34 | 6.83 | - | - | - | Upgrade
|
| P/FCF Ratio | 342.45 | 439.73 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 113.14 | 189.00 | 752.80 | - | - | - | Upgrade
|
| EV/Sales Ratio | 1.06 | 2.12 | 4.80 | - | - | - | Upgrade
|
| EV/EBITDA Ratio | 15.43 | 29.25 | 35.56 | - | - | - | Upgrade
|
| EV/EBIT Ratio | 16.19 | 30.04 | 36.68 | - | - | - | Upgrade
|
| EV/FCF Ratio | 354.09 | 438.80 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.08 | 0.08 | 0.42 | 0.03 | 0.09 | Upgrade
|
| Debt / EBITDA Ratio | 0.31 | 0.50 | 0.49 | 0.71 | 0.04 | 0.21 | Upgrade
|
| Debt / FCF Ratio | 7.15 | 7.66 | - | 3.08 | 0.04 | 0.10 | Upgrade
|
| Net Debt / Equity Ratio | -0.01 | -0.01 | -0.06 | 0.26 | -0.14 | -0.18 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.10 | -0.09 | -0.37 | 0.44 | -0.22 | -0.41 | Upgrade
|
| Net Debt / FCF Ratio | -2.20 | -1.43 | 5.53 | 1.90 | -0.19 | -0.20 | Upgrade
|
| Asset Turnover | 1.90 | 1.62 | 1.16 | 1.79 | 1.84 | 2.30 | Upgrade
|
| Inventory Turnover | 9.08 | 11.26 | 7.53 | 22.88 | 8.96 | 14.50 | Upgrade
|
| Quick Ratio | 0.87 | 1.11 | 0.99 | 0.97 | 0.44 | 0.58 | Upgrade
|
| Current Ratio | 1.61 | 1.82 | 1.51 | 1.39 | 0.84 | 0.98 | Upgrade
|
| Return on Equity (ROE) | 18.30% | 16.79% | 24.98% | 66.14% | 71.37% | 40.49% | Upgrade
|
| Return on Assets (ROA) | 7.75% | 7.15% | 9.46% | 26.40% | 19.63% | 8.89% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.64% | 16.06% | 23.77% | 53.60% | 77.53% | 47.79% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.10% | 14.10% | 14.50% | 40.30% | 63.30% | 34.60% | Upgrade
|
| Earnings Yield | 4.37% | 2.20% | 2.02% | - | - | - | Upgrade
|
| FCF Yield | 0.29% | 0.23% | -0.19% | - | - | - | Upgrade
|
| Dividend Yield | 0.15% | 0.07% | 0.09% | - | - | - | Upgrade
|
| Payout Ratio | 1.76% | 4.06% | 2.88% | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -3.88% | -4.28% | -38.35% | -2.10% | - | - | Upgrade
|
| Total Shareholder Return | -3.72% | -4.21% | -38.27% | -2.10% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.